SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection results in coagulation activation although it is usually not associated with consumption coagulopathy. D‐dimers are also commonly elevated despite systemic hypofibrinolysis. To understand these unusual features of coronavirus dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Toomer, Kevin H., Gerber, Gloria F., Zhang, Yifan, Daou, Laetitia, Tushek, Michael, Hooper, Jody E., Francischetti, Ivo M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Sickle Cell, Thrombosis, and Classical Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188457/
https://www.ncbi.nlm.nih.gov/pubmed/37206290
http://dx.doi.org/10.1002/jha2.654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188457/
https://www.ncbi.nlm.nih.gov/pubmed/37206290
http://dx.doi.org/10.1002/jha2.654

Ejemplares similares